NIH Funding Opportunities
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 5 hours 34 min ago
The National Institutes of Health (NIH) Sexual and Gender Minority Research Office Request for Letters of Intent and Nominations for SGM Investigator Awards Program
Notice NOT-OD-19-103 from the NIH Guide for Grants and Contracts
HEAL Initiative: Early Phase Pain Investigation Clinical Network - Specialized Clinical Centers (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-19-036 from the NIH Guide for Grants and Contracts. (RFA-NS-19-025 is being reissued to accommodate an additional receipt date). The purpose of this funding opportunity announcement (FOA) is to invite applications for the Specialized Clinical Centers (hubs) of the Early Phase Pain Investigation Clinical Network (EPPIC-Net). EPPIC-Net will serve as the cornerstone of the NIHs Helping to End Addiction Long-term (HEAL) Initiative. EPPIC-Net will provide a robust and readily accessible infrastructure for carrying out in depth phenotyping and biomarker studies in patients with specific pain conditions, and the rapid design and performance of high-quality Phase 2 clinical trials to test promising novel therapeutics for pain from partners in academia or industry. Studies will bring intense focus to patients with well-defined pain conditions and high unmet therapeutic needs. EPPIC-Net will consist of one Clinical Coordinating Center (CCC), one Data Coordinating Center (DCC) and approximately 10 specialized clinical centers (hubs). The purpose of this funding opportunity announcement (FOA) is to invite applications for the hubs within EPPIC-Net. A hub will typically be a regional medical center that will actively enroll subjects into clinical trials and studies performed in EPPIC-Net. Each hub should have ready access to patient populations with specific pain conditions and have expertise in characterization of that pain condition. A hub will additionally provide scientific leadership and administrative oversight to its multiple (2-10) satellite sites (spokes). This FOA solicits applications EPPIC-Net Specialized Clinical Centers. Separate FOAs have been issued to solicit applications for the Clinical Coordinating Center (RFA-NS-18-036) and Data Coordinating Center (RFA-NS-18-035). Clinical trials conducted through EPPIC-Net may come from a variety of sources including the HEAL Partnership, as described above, or from separate NIH funding announcements.
Notice of Special Interest: Administrative Supplements for Alternatives to the Use of Human Fetal Tissues for NIH Tissue Chip Programs
Notice NOT-TR-19-019 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-099 from the NIH Guide for Grants and Contracts
Limited Competition: Interdisciplinary Complementary and Integrative Health Clinical Research Training (T90/R90 Independent Clinical Trial Not Allowed)
Funding Opportunity RFA-AT-19-010 from the NIH Guide for Grants and Contracts. The National Center for Complementary and Integrative Health (NCCIH) seeks to support interdisciplinary clinical research training to improve the capacity of the integrative health field to carry out rigorous research. This Funding Opportunity Announcement (FOA) solicits renewal applications to support training partnerships between institutions with research intensive environments (e.g., institutions with a Clinical and Translational Science Award (CTSA) or T32 programs) and institutions focused on clinical training of practitioners in complementary modalities and disciplines that have faculty with substantial interest in rigorous clinical research. The program will support mentored research training with hands-on mentored experiences in clinical research within NCCIH's Strategic Plan and didactic activities in clinical research methodology and integrative health. The funded training partnership is expected to generate a cadre of clinician scientists who participate in multi-disciplinary teams engaged in complementary and integrative health research. This FOA does not allow appointed T90 Trainees or R90 Participants to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.
NEI Notice of Participation in PAR-19-134, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
Notice NOT-EY-19-024 from the NIH Guide for Grants and Contracts
NEI Notice of Participation in PAR-19-135, "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)"
Notice NOT-EY-19-025 from the NIH Guide for Grants and Contracts
Notice of Correction to NOT-RM-19-001 Request for Information (RFI): Institutional Accountability to Promote Inclusive Excellence
Notice NOT-RM-19-006 from the NIH Guide for Grants and Contracts
Notice Announcing the National Human Genome Research Institutes Genomics in Medicine and Health Strategic Planning Workshop
Notice NOT-HG-19-020 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-257 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) announces a program that provides NIAMS-supported K08 and K23 recipients the opportunity to apply for Small Grant (R03) support at some point during the second to fourth year of their K award. Through this FOA, the NIAMS is seeking to enhance the capability of its clinical scientists to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that provide preliminary data to support a subsequent R01, or equivalent, application. Clinical trials of any phase will not be supported by this FOA.
Notice of Special Interest for Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional)
Notice NOT-OD-19-102 from the NIH Guide for Grants and Contracts
NHLBI Limitations on Clinical Trial Applications Submitted to the NIH Parent (R01 Clinical Trial Required) Funding Opportunity Announcement (FOA)
Notice NOT-HL-19-690 from the NIH Guide for Grants and Contracts
Notice of Change to Activity Codes allowed for Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional) PA-19-217
Notice NOT-OD-19-101 from the NIH Guide for Grants and Contracts
Limited Competition: Modular Budget Research Project Grant for NIH Nurse Scientist Scholars (R01 Clinical Trial Optional)
Funding Opportunity PAR-19-256 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage modular budget R01 grant applications from nurse scientists who are currently or were recently supported by an NIH Career Development (K) award. This opportunity is limited to those K awardee nurse scientists who have not yet earned an R01 equivalent award. Through this opportunity, NINR seeks to enhance the transition of nurse scientists to independent investigator status.
Notice to Extend the Expiration Date of PAR-16-204 "NLM Career Development Award in Biomedical Informatics and Data Science (K01)" and Discontinue the FOA.
Notice NOT-LM-19-004 from the NIH Guide for Grants and Contracts
Invitation for Input on the 2020 National Research Summit on Care, Services, and Supports for Persons with Dementia and their Caregivers
Notice NOT-AG-19-016 from the NIH Guide for Grants and Contracts
Notice of Change to PAR-18-185, "Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional)"
Notice NOT-AG-19-020 from the NIH Guide for Grants and Contracts
Notice of Change to PAR-18-186, "Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional)"
Notice NOT-AG-19-021 from the NIH Guide for Grants and Contracts
Notice of NIAID's Participation in RFA-OD-19-020 "Building Interdisciplinary Research Careers in Women's Health (K12 Clinical Trial Optional)"
Notice NOT-AI-19-057 from the NIH Guide for Grants and Contracts
Notice of Clarification of Institutional Eligibility for PAR-19-218 "Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)
Notice NOT-GM-19-038 from the NIH Guide for Grants and Contracts
NIH Funding Opportunities
- Registration Open for the ICARE Academy on September 10-11, 2019, in Alexandria, VA
- Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed)
- Center of Excellence for Natural Product Drug interaction Research (U54, Clinical Trial Required)
- Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R21)
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)